Incentive Spirometry: A Guide for Clinical Practice (2026)

Incentive spirometry is a commonly used lung expansion therapy designed to prevent and manage pulmonary complications, particularly atelectasis. It is a simple, noninvasive technique that encourages patients to take slow, deep breaths to improve lung function.

Frequently used in postoperative care and in patients with limited mobility, this therapy helps restore normal breathing patterns and maintain alveolar stability.

By promoting sustained maximal inspiration, incentive spirometry supports adequate ventilation, improves oxygenation, and reduces the risk of complications associated with shallow breathing.

What Is Incentive Spirometry?

Incentive spirometry is a noninvasive respiratory therapy technique used to promote deep breathing and improve lung expansion. It involves a handheld device that provides visual feedback as the patient inhales slowly and deeply. The goal is to perform sustained maximal inspiration, which mimics a natural deep breath or sigh and helps reopen collapsed alveoli.

This therapy is commonly used in postoperative patients and individuals at risk for decreased lung volumes, such as those on prolonged bed rest or with chronic lung conditions.

By encouraging slow, controlled inhalation followed by a brief breath-hold, incentive spirometry improves ventilation, enhances oxygenation, and helps prevent complications like atelectasis. Because it is patient-driven, its effectiveness depends on proper technique, consistent use, and patient motivation.

Physiologic Basis of Incentive Spirometry

The effectiveness of incentive spirometry is based on fundamental principles of pulmonary physiology. When a patient performs a sustained maximal inspiration, several important changes occur within the lungs.

First, there is an increase in transpulmonary pressure. This pressure difference between the alveoli and the pleural space allows the lungs to expand more fully. As lung volume increases from functional residual capacity toward total lung capacity, previously collapsed or under-ventilated alveoli begin to reopen.

Second, the inspiratory breath-hold plays a key role. Holding the breath for several seconds allows time for gas redistribution throughout the lungs. This promotes alveolar recruitment and improves ventilation to areas that may have been poorly ventilated.

Third, collateral ventilation pathways become more active. These pathways allow air to move between adjacent alveoli, further enhancing lung expansion and reducing the likelihood of collapse. Together, these physiologic effects improve oxygenation, enhance ventilation distribution, and support overall lung function.

Indications for Incentive Spirometry

Incentive spirometry is primarily indicated for patients who are at risk for decreased lung expansion or developing atelectasis. It is most commonly used in the following situations:

Postoperative Patients

Patients recovering from surgery, especially abdominal or thoracic procedures, are at high risk for pulmonary complications. Pain, anesthesia, and reduced mobility contribute to shallow breathing and impaired lung expansion. Incentive spirometry helps counteract these effects by encouraging deep breathing.

Patients on Prolonged Bed Rest

Immobility reduces normal respiratory effort and increases the risk of secretion retention and alveolar collapse. Incentive spirometry promotes regular lung expansion in these patients.

Chronic Lung Disease

Patients with conditions such as COPD may benefit from incentive spirometry to support lung expansion and improve ventilation patterns, although its effectiveness depends on disease severity and patient ability.

Restrictive Disorders

Individuals with neuromuscular weakness, spinal cord injuries, or diaphragmatic dysfunction may have reduced inspiratory capacity. Incentive spirometry can help maintain lung volumes and prevent complications.

Patients with Shallow Breathing Patterns

Any condition that leads to hypoventilation or reduced inspiratory effort may warrant the use of incentive spirometry as part of a broader pulmonary care plan.

Contraindications and Limitations

Although incentive spirometry is widely used, it is not appropriate for all patients. Its effectiveness depends heavily on patient participation and effort.

Absolute and Relative Contraindications

• Inability to follow instructions or cooperate
• Severe cognitive impairment
• Very low inspiratory capacity
• Untreated pneumothorax
• Severe pain that limits deep breathing

Note: Patients who cannot generate sufficient inspiratory effort may not benefit from this therapy. For example, individuals with extremely low vital capacity or inspiratory capacity may require alternative interventions.

Limitations

One of the most important limitations is that incentive spirometry is effort-dependent. If the patient is not motivated or properly instructed, the therapy becomes ineffective. Additionally, it has limited benefit in treating severe atelectasis. In such cases, other therapies such as positive airway pressure techniques may be more appropriate.

Equipment and Device Types

Incentive spirometers are simple devices designed to provide visual feedback during inhalation. Despite their simplicity, they play an important role in respiratory therapy.

Volume-Oriented Devices

These devices measure the volume of air inspired. A piston or movable indicator rises as the patient inhales, providing a clear visual representation of inspiratory effort.

Advantages include:

• More accurate measurement of inspiratory volume
• Encouragement of slow, deep breathing
• Better feedback for achieving target volumes

Flow-Oriented Devices

These devices measure inspiratory flow rather than volume. They typically use lightweight balls that rise in response to airflow.

Advantages include:

• Simple design
• Easy to use
• Visual feedback through moving indicators

Note: They may encourage faster breathing rather than slow, controlled inhalation, which can reduce effectiveness if not properly coached.

Proper Technique and Patient Instruction

Correct technique is essential for achieving the desired physiologic effects of incentive spirometry. Patient education should be clear, simple, and reinforced regularly.

Step-by-Step Procedure

• Positioning: The patient should sit upright or as close to an upright position as possible to maximize lung expansion.
• Preparation: The patient exhales normally before beginning the maneuver.
• Seal the Mouthpiece: The lips should form a tight seal around the mouthpiece to prevent air leakage.
• Slow, Deep Inhalation: The patient inhales slowly and deeply, aiming to raise the indicator to the target level.
• Breath-Hold: The patient holds the breath for several seconds to allow for alveolar recruitment.
• Exhalation: The patient exhales normally and rests before repeating the maneuver.

Coaching Tips

• Encourage diaphragmatic breathing
• Avoid rapid or shallow breaths
• Provide positive reinforcement
• Set achievable volume goals

Note: Proper coaching significantly improves patient compliance and overall effectiveness.

Frequency and Duration of Use

The frequency of incentive spirometry is based on physiologic principles and clinical practice guidelines.

Patients are generally instructed to perform:

• 5 to 10 breaths per session
• At least once every hour while awake

This recommendation reflects the natural tendency of healthy individuals to take periodic deep breaths throughout the day. Rest periods between breaths may be necessary to prevent fatigue or hyperventilation.

Note: Consistency is more important than intensity. Regular use throughout the day is key to maintaining lung expansion and preventing complications.

Monitoring and Evaluation

Monitoring the effectiveness of incentive spirometry involves both objective and subjective assessment.

Key Parameters to Monitor

• Inspiratory volumes achieved
• Number of sessions completed
• Breath-hold duration
• Patient technique and compliance

Clinical Indicators of Improvement

• Improved oxygen saturation
• Increased vital capacity
• Clearer breath sounds
• Improved chest imaging findings

Note: Clinicians should also assess for signs of ineffective therapy, such as persistent hypoventilation or worsening respiratory status.

Complications and Adverse Effects

Incentive spirometry is generally considered safe, but improper use or excessive frequency can lead to mild complications. The most common issue is hyperventilation, which may result in dizziness, lightheadedness, or tingling sensations. This occurs when patients breathe too rapidly or perform too many repetitions without adequate rest.

Another potential complication is respiratory alkalosis, which develops when excessive carbon dioxide is eliminated from the body due to overbreathing. While typically mild and self-limiting, it can be uncomfortable for patients.

Fatigue is also a concern, particularly in postoperative or debilitated patients. Repeated deep breathing efforts can lead to exhaustion if not spaced appropriately.

In some cases, patients may experience bronchospasm, especially those with reactive airway conditions. This can result in wheezing or shortness of breath during or after the maneuver. Although rare, pulmonary barotrauma is a possible complication if excessive pressure is generated during inhalation. Proper instruction and monitoring significantly reduce this risk.

Clinical Effectiveness and Evidence

The clinical effectiveness of incentive spirometry has been widely studied, with mixed results. While it is commonly used to prevent postoperative pulmonary complications, evidence supporting its superiority over other interventions is limited.

Some studies suggest that incentive spirometry alone does not significantly reduce the incidence of atelectasis or pneumonia when compared to standard care or alternative therapies. This is particularly noted in patients undergoing cardiac or upper abdominal surgery.

However, incentive spirometry may still provide benefit when used as part of a comprehensive pulmonary care program. Its value lies in encouraging deep breathing, promoting patient engagement, and reinforcing proper respiratory mechanics.

Note: Because of these findings, incentive spirometry should not be relied upon as a standalone therapy. Instead, it should be integrated with other interventions to maximize effectiveness.

Comparison with Other Lung Expansion Therapies

Incentive spirometry is one of several techniques used to promote lung expansion and prevent pulmonary complications. Understanding how it compares to other therapies helps guide appropriate clinical use.

Deep Breathing and Coughing Exercises

These techniques are often used alongside incentive spirometry. They help mobilize secretions, improve ventilation, and maintain airway patency. While simple and effective, they lack the visual feedback that incentive spirometry provides.

Early Ambulation

Encouraging patients to move and walk as soon as possible after surgery is one of the most effective ways to improve lung function. Ambulation enhances ventilation, circulation, and secretion clearance.

Continuous Positive Airway Pressure (CPAP)

CPAP delivers a constant level of positive pressure to keep the airways open. It is particularly useful in patients with more significant lung collapse or those who cannot perform incentive spirometry effectively.

Intermittent Positive Pressure Breathing (IPPB)

IPPB provides assisted breaths using a mechanical device. It is often used when patients are unable to generate sufficient inspiratory effort on their own.

Key Differences

• Incentive spirometry is patient-driven and requires active participation
• CPAP and IPPB provide mechanical assistance
• Ambulation and breathing exercises address overall pulmonary function and mobility

Note: If a patient cannot perform incentive spirometry correctly or fails to show improvement, alternative therapies should be considered.

Role in Pulmonary Rehabilitation and Postoperative Care

Incentive spirometry plays an important role in both acute care and rehabilitation settings. It is most commonly used in postoperative patients to prevent complications associated with reduced lung expansion.

Following surgery, factors such as pain, sedation, and immobility contribute to shallow breathing and decreased ventilation. Incentive spirometry helps counteract these effects by promoting regular deep breaths and maintaining alveolar stability.

In pulmonary rehabilitation, it may be used as part of a broader strategy to improve breathing patterns and support lung function. However, its effectiveness depends on patient adherence and proper technique.

Note: Education and motivation are essential. Patients who understand the purpose of the therapy and are actively engaged are more likely to achieve positive outcomes.

Patient Education and Compliance

The success of incentive spirometry depends heavily on patient compliance. Without consistent and proper use, the therapy provides little benefit.

Key Elements of Patient Education

• Explain the purpose of the therapy in simple terms
• Demonstrate proper technique
• Set realistic and achievable goals
• Reinforce the importance of regular use

Note: Patients should understand that the goal is not speed but slow, controlled inhalation with a sustained breath-hold.

Strategies to Improve Compliance

• Use visual goals and progress tracking
• Provide regular encouragement and feedback
• Address barriers such as pain or discomfort
• Incorporate the therapy into a daily routine

Note: Pain management is particularly important in postoperative patients. If pain is not controlled, patients may avoid deep breathing, reducing the effectiveness of the therapy.

Discontinuation Criteria

Incentive spirometry should not be continued indefinitely. Its use should be reassessed regularly based on patient progress and clinical outcomes.

Common Reasons for Discontinuation

• Resolution of the underlying condition
• Patient regains normal breathing patterns
• Improved mobility and activity level
• Lack of effectiveness despite proper use
• Development of adverse effects

Note: In many postoperative patients, incentive spirometry is discontinued within several days to one week as lung function improves and the risk of complications decreases.

Key Takeaways

For respiratory therapy students and clinicians, several important concepts should be emphasized:

• Incentive spirometry promotes sustained maximal inspiration
• It is primarily used for the prevention of atelectasis
• The therapy is patient effort dependent
• Proper technique and education are essential
• It is not effective for severe lung collapse
• Contraindicated in untreated pneumothorax
• Alternative therapies should be used when necessary

Note: Understanding these principles is essential for both clinical application and exam preparation.

Incentive Spirometry Practice Questions

1. What is incentive spirometry (IS)?
A lung-expansion technique that uses a handheld device to provide visual feedback while a patient performs slow, deep inspirations with an end-inspiratory hold.

2. What is another common name for incentive spirometry?
Sustained maximal inspiration (SMI).

3. What is the main physiologic goal of incentive spirometry?
To increase lung volume by promoting a slow, deep inspiration toward maximal inspiration and sustaining it briefly to help recruit alveoli.

4. How does incentive spirometry “mimic a sigh” in clinical terms?
It encourages periodic deep breaths (instead of repetitive shallow tidal breaths) that expand lung units toward higher volumes.

5. Why are postoperative patients at elevated risk of atelectasis?
Pain, anesthesia effects, immobility, and shallow breathing reduce lung volumes and impair periodic deep breaths and cough.

6. What clinical problem is incentive spirometry most commonly intended to prevent or improve?
Atelectasis or risk of atelectasis in patients who can cooperate and perform deep breaths.

7. Is incentive spirometry primarily an oxygenation therapy or a lung-volume therapy?
Primarily lung-volume therapy (lung expansion); oxygenation may improve secondarily if atelectasis or hypoventilation is corrected.

8. What does incentive spirometry not directly measure?
It does not directly measure oxygen saturation, ventilation (PaCO₂), or airway resistance; it provides feedback about inspiratory flow or inspiratory volume depending on the device.

9. What is the difference between diagnostic spirometry and incentive spirometry?
Diagnostic spirometry measures lung function for testing; incentive spirometry is a coached breathing exercise used therapeutically to promote lung expansion.

10. What is the key mechanism by which deep inspiration helps reopen collapsed lung units?
A deep breath increases transpulmonary pressure and inspiratory volume, which can help recruit collapsed alveoli and improve ventilation distribution.

11. Why is an end-inspiratory “hold” coached during incentive spirometry?
A brief hold increases time at high lung volume, supporting alveolar recruitment and gas redistribution into slower-filling units.

12. What is a typical coached breath-hold duration during incentive spirometry?
Commonly about 3–5 seconds, and often around 5 seconds if tolerated.

13. What two main categories of incentive spirometers are commonly taught?
Volume-oriented and flow-oriented devices.

14. How does a volume-oriented incentive spirometer provide feedback?
By showing the inspired volume (often via a rising piston/bellows aligned to a volume scale).

15. How does a flow-oriented incentive spirometer provide feedback?
By showing inspiratory flow (often via one to three balls/disks that rise based on flow rate).

16. Why can flow-oriented devices unintentionally encourage an ineffective breathing pattern?
Patients may inhale too fast to “lift the balls,” increasing inspiratory flow but not necessarily maximizing sustained inspiratory volume.

17. Why are volume-oriented devices often preferred in respiratory care teaching?
They emphasize slow, deep, volume-based inhalation and are commonly associated with lower imposed work and larger inspiratory volumes in many contexts.

18. What common visual cue on many volume-oriented devices helps prevent inhaling too fast?
A small flow indicator chamber/ball that rises too high if the patient inhales too rapidly.

19. Why must many volume-oriented devices be held upright?
If tilted, the piston/bellows may not move freely, and the volume reading becomes unreliable.

20. Why can mouth leaks reduce the effectiveness of incentive spirometry?
Leaks reduce the inspired volume and disrupt the slow, sustained inspiration needed for lung expansion.

21. What bedside position generally supports the best performance of incentive spirometry?
Upright sitting (or as upright as tolerated).

22. Why is upright positioning helpful for incentive spirometry?
It improves diaphragmatic excursion, lung expansion, and reduces abdominal compression on the diaphragm.

23. What is the basic starting breath before an IS maneuver?
Exhale normally (or gently) to a comfortable end-expiratory level, then begin a slow, deep inhalation.

24. What is a common incorrect technique that reduces benefit?
A series of short “sniffs” or rapid shallow inhalations instead of one slow, sustained, deep breath.

25. What is a “return demonstration,” and why does it matter for IS?
It is the patient demonstrating the technique back to the clinician to confirm correct use; IS is ineffective if performed incorrectly.

26. What does it mean if a patient can’t keep the “flow ball” in the target zone during a volume device maneuver?
They are likely inhaling too fast or too slow; coaching should adjust speed toward slow-to-moderate flow.

27. What is the role of goal-setting (target marker) on an incentive spirometer?
It provides an attainable target volume/flow that motivates effort and supports tracking progress.

28. Should goals be fixed or adjusted over time?
They should be adjusted based on patient performance and recovery trajectory (progression is expected in many postoperative patients).

29. What is a practical reason incentive spirometry often fails in real-world use?
Poor adherence and inconsistent technique outside supervised sessions.

30. Why is patient motivation important for IS effectiveness?
Because the technique is effort-dependent and requires repeated correct performance.

31. According to respiratory-care guidance, is incentive spirometry recommended as a stand-alone routine method to prevent postoperative pulmonary complications?
No; IS alone is not recommended for routine prevention—use it as part of a broader lung-expansion and mobilization plan.

32. Name four common components often paired with incentive spirometry in postoperative pulmonary care.
Deep breathing exercises, directed coughing, early mobilization/ambulation, and optimal analgesia.

33. Why is analgesia important for incentive spirometry success after surgery?
Pain limits deep inspiration; improving pain control enables deeper breaths and more effective lung expansion.

34. What is “splinting,” and how does it relate to patients using IS after abdominal surgery?
Splinting is supporting an incision (often with a pillow) to reduce pain during deep breathing and coughing, improving participation.

35. What is one classic indication for IS in the perioperative period?
Patients at risk for atelectasis due to thoracic or upper abdominal surgery who can cooperate with the technique.

36. Why does thoracic or upper abdominal surgery increase atelectasis risk?
These surgeries often impair diaphragmatic movement and cause painful breathing, promoting shallow breaths and reduced lung volumes.

37. What is another common indication for IS besides surgery?
Prolonged bed rest or immobility with risk for reduced lung volumes and atelectasis.

38. When atelectasis is already present, how is IS typically used?
As one component of lung expansion therapy to help re-expand collapsed regions, alongside coughing and mobilization as appropriate.

39. Why might a restrictive pattern with diaphragmatic dysfunction be a context for considering IS?
These patients may benefit from coached deep inspirations to improve inspiratory volumes and reduce atelectasis risk (if they can perform correctly).

40. What patient population is specifically mentioned in respiratory-care guidance as potentially benefiting from IS to prevent atelectasis related to acute chest syndrome?
Patients with sickle cell disease.

41. In chronic lung disease, what key factor determines whether IS is reasonable?
Whether the patient can perform the maneuver correctly without undue distress and can generate adequate inspiratory volumes.

42. What is a reasonable approach if a patient cannot perform IS due to poor cooperation or inability to follow commands?
Choose an alternative lung expansion strategy that does not rely on patient cooperation (based on clinical context and institutional protocols).

43. Give examples of alternative lung expansion modalities used when IS is not feasible.
CPAP or other positive airway pressure therapies, and in selected cases clinician-delivered hyperinflation approaches per protocol.

44. What is the key “patient selection” idea behind IS?
It works best for patients who are alert, cooperative, can seal the mouthpiece, and can repeat the maneuver regularly.

45. What does it mean if a provider orders IS for “preoperative screening”?
To document baseline inspiratory flow/volume and teach technique before surgery so postoperative goals and technique are established.

46. What is the most fundamental contraindication-like barrier to using IS effectively?
Inability to follow instructions or demonstrate correct technique.

47. Why is heavy sedation a practical reason to avoid IS?
The patient cannot reliably cooperate or generate a consistent, correct maneuver.

48. Why is delirium or significant confusion a barrier to IS?
It prevents correct technique and consistent adherence, making the therapy ineffective or unsafe.

49. Why can inadequate pain control function as a “contraindication” to IS?
Pain can prevent deep breathing and lead to shallow rapid attempts that increase dizziness or hyperventilation without lung expansion benefit.

50. What vital capacity threshold is commonly used to identify patients unlikely to generate an adequate inspiration for IS?
Vital capacity less than about 10 mL/kg.

51. What inspiratory capacity threshold is commonly used to identify patients unlikely to generate an adequate inspiration for IS?
Inspiratory capacity less than about 33% of predicted.

52. What is the most common physiologic complication of performing IS too rapidly?
Hyperventilation leading to respiratory alkalosis and symptoms such as dizziness or tingling.

53. What should you coach a patient to do if they become dizzy during IS?
Stop the maneuver, take a few normal breaths, and resume more slowly when symptoms resolve.

54. Why can IS cause hypoxemia in some patients if done improperly?
If oxygen therapy is interrupted for too long, such as removing an oxygen mask during repeated maneuvers, SpO₂ can drop.

55. How can you reduce the risk of desaturation in a patient who needs continuous oxygen during IS?
Keep oxygen delivery in place when feasible, such as using a nasal cannula, minimize interruption time, and monitor SpO₂.

56. What is a practical hazard related to pain and IS?
Pain can lead to poor technique, reduced inspired volume, and patient refusal, decreasing effectiveness.

57. Why can fatigue be a concern with IS in frail patients?
Repeated maximal inspirations may tire the patient, reducing quality of subsequent maneuvers and overall adherence.

58. What complication can occur if a patient does repeated deep breaths too quickly without rest?
Lightheadedness and ineffective hyperventilation patterns rather than sustained lung expansion.

59. What infection-control concern applies to incentive spirometers?
Shared equipment must be appropriately disposed of or disinfected per manufacturer guidance, and standard precautions apply.

60. Why is “ineffective unless performed as instructed” a major limitation of IS?
Because incorrect technique, such as fast breaths, leaks, no breath hold, or poor repetition, negates the intended lung expansion effect.

61. What are the first three steps you would teach for IS technique?
Sit upright, hold the device upright, and seal lips tightly around the mouthpiece.

62. What is the next key step after sealing the mouthpiece?
Inhale slowly and deeply to raise the piston or balls to the target.

63. What is the key coaching cue about inspiratory speed?
Slow and steady, avoiding rapid inhalation.

64. What should happen at the point of maximum inhalation?
The patient pauses briefly with an end-inspiratory hold, then removes the mouthpiece and exhales normally.

65. Why is normal exhalation recommended instead of forceful blowing into the device?
In most devices, exhalation into the device is not needed and can disrupt measurement and technique; the goal is sustained inspiration, not forced expiration.

66. How many successive IS breaths should be grouped together for most patients before resting or coughing?
A small set, often about 10 breaths, with brief rests between breaths to avoid hyperventilation.

67. What is a common frequency instruction while awake in many clinical settings?
Perform a set of about 10 breaths roughly every 1 to 2 hours while awake, or as ordered.

68. Why is it useful to place the IS device within the patient’s reach?
Accessibility improves adherence and allows independent practice between supervised sessions.

69. What is an appropriate way to verify that the patient is inhaling rather than exhaling through the mouthpiece?
Observe the piston or ball movement and the patient’s effort pattern; coaching is needed if the patient blows into the device.

70. What is the key difference in coaching a flow-oriented device versus a volume-oriented device?
Flow devices require coaching to avoid breathing too fast to lift the balls, while volume devices require coaching toward slow deep inhalation with proper flow control.

71. How do you coach a patient who keeps shooting the flow ball to the top, indicating too fast inhalation?
Encourage slower inhalation and include short rests between attempts until the ball stays within the target zone.

72. How do you coach a patient who cannot reach the target volume early after surgery?
Reassure the patient, optimize pain control and positioning, adjust goals to a realistic level, and progress gradually.

73. If a patient’s mouth seal is poor, what can you do?
Reposition the mouthpiece, coach a tighter lip seal, consider alternative mouthpiece options if available, and reassess for facial weakness.

74. Why should you monitor respiratory rate and patient work of breathing during IS sessions?
An increasing respiratory rate or signs of distress suggest the patient may be overexerting, hyperventilating, or not tolerating the maneuver.

75. What should you do if the patient becomes markedly short of breath during IS?
Stop the maneuver, reassess oxygenation and clinical status, check technique, and consider adjusting intensity, frequency, or using alternative therapy.

76. Why is “direct supervision of every use” often unnecessary after mastery?
Once technique is correct, patients can practice independently, but periodic reassessment is still needed for adherence and technique quality.

77. What should you reassess periodically even after a patient demonstrates correct IS technique?
Frequency of use, number of breaths per session, achieved volume or flow, breath-hold quality, and motivation or effort.

78. What is a simple way to integrate airway clearance with IS?
After a set of deep breaths, coach directed coughing to mobilize and clear secretions.

79. Why does combining IS with early mobilization make physiologic sense?
Ambulation improves ventilation distribution, enhances secretion clearance, and reduces the effects of immobility that contribute to atelectasis.

80. What is a key reason to teach IS preoperatively when possible?
Patients learn better before postoperative pain and sedation, enabling better technique and adherence after surgery.

81. What clinical findings can indicate improvement in atelectasis with lung expansion therapy?
Lower respiratory rate, improved breath sounds, improved oxygenation, and improved imaging when clinically indicated.

82. What is one imaging modality commonly used to confirm atelectasis improvement or persistence?
Chest radiography, when clinically needed.

83. What bedside oxygenation measures may improve if IS helps reverse atelectasis?
SpO₂ and reduced FiO₂ requirement, and in some cases improved PaO₂ if arterial blood gases are obtained.

84. What part of the IS regimen should be documented for clinical tracking?
Achieved inspiratory volume or flow goals, patient technique quality, and adherence including frequency and number of sets.

85. Why is documenting “minutes of treatment” less meaningful than documenting achieved volumes and adherence?
IS is a maneuver-based therapy; the therapeutic dose is better reflected by correct repetitions and achieved inspiratory volumes.

86. What is a realistic short-term goal for many postoperative patients early after surgery?
Achieve consistent correct technique with gradually improving inspiratory volumes over days as pain decreases and mobility increases.

87. What is the practical meaning of “evidence is lacking for a specific IS frequency”?
No single schedule is proven best; clinicians use reasonable, commonly taught regimens and adjust to patient tolerance and goals.

88. Provide an example of commonly suggested IS dosing patterns used in clinical trials.
Approximately 10 breaths every 1–2 hours while awake, or similar structured sets distributed across the day.

89. What is a key sign that IS is being done incorrectly even if the patient is using the device often?
Little to no improvement in inspired volume or flow, a fast breathing pattern, absent breath hold, or persistent poor technique.

90. When should a respiratory therapist consider stopping or de-escalating IS?
When the patient is consistently ambulatory, breathing deeply on their own, lung expansion goals are met, and there is no ongoing atelectasis risk requiring continued device use according to the clinical plan.

91. What is the guideline-based summary of evidence for IS used alone to prevent postoperative pulmonary complications in routine preoperative and postoperative care?
It is not recommended as a stand-alone routine intervention.

92. Why do many studies struggle to show clinical benefit from IS?
Because outcomes depend heavily on correct technique and adherence, and adherence is often low or not consistently measured.

93. In which thoracic surgery subgroup has some later literature suggested potential benefit may be more plausible?
Higher-risk patients, such as some individuals with COPD, where targeted use and adherence may have greater impact.

94. Why is IS still commonly used despite mixed evidence?
It is relatively inexpensive, encourages patients to perform breathing exercises, and is easy to teach as part of a broader care plan.

95. What is the most defensible way to describe the role of IS in postoperative care?
A coaching tool for deep breathing within a multimodal pulmonary complication prevention strategy, rather than a proven stand-alone solution.

96. What is one reason deep breathing exercises may be clinically comparable to IS in some settings?
The therapeutic effect comes from the deep sustained breath itself; the device mainly provides feedback and motivation.

97. What is the relationship between IS and directed cough in preventing complications?
IS supports lung expansion while coughing promotes secretion clearance; together they address key contributors to postoperative pulmonary complications.

98. How should IS be adapted for a patient with high oxygen needs?
Ensure oxygenation is maintained during sessions, minimize interruptions in oxygen delivery, monitor SpO₂, and pace the maneuver to avoid distress.

99. What is the safest interpretation of a patient who cannot achieve large volumes on IS immediately after major surgery?
Lower volumes are expected early; focus on proper technique, adequate pain control, realistic goals, and gradual improvement rather than forcing maximal targets.

100. What is the best-practice way to use incentive spirometry in respiratory care decision-making?
Confirm the patient can perform the technique correctly, integrate IS with breathing exercises, coughing, mobilization, and analgesia, monitor response and adherence, and escalate to alternative lung expansion therapies if IS is not feasible or effective.

Final Thoughts

Incentive spirometry is a simple and widely used technique that supports lung expansion and helps prevent pulmonary complications in at-risk patients. It works by encouraging sustained maximal inspiration, which promotes alveolar recruitment and improves ventilation.

While its effectiveness as a standalone therapy is limited, it remains valuable when combined with other interventions such as early ambulation and airway clearance techniques.

Success depends on proper patient selection, education, and consistent use. When applied appropriately, it contributes to improved respiratory outcomes and supports recovery in a variety of clinical settings.